Sign in to continue:

Thursday, March 12th, 2026

Healthcare Triangle, Inc. Announces $2 Million Share Repurchase Program Approved by Board of Directors




Healthcare Triangle, Inc. Announces \$2 Million Share Repurchase Plan – Key Investor Insights

Healthcare Triangle, Inc. Approves \$2 Million Share Repurchase Plan: What Investors Need to Know

Key Developments Announced

Pleasanton, Calif., March 11, 2026 – Healthcare Triangle, Inc. (Nasdaq: HCTI), a leading provider of digital transformation solutions to the healthcare and life sciences industries, has announced a major new capital allocation initiative designed to unlock shareholder value and signal management’s confidence in the company’s future. The Board of Directors has formally approved a share repurchase program, authorizing the company to buy back up to \$2,000,000 of its outstanding common stock.

Key Points from the Announcement

  • Share Repurchase Program Details: The Board of Directors approved the “2026 Share Repurchase Plan” on March 9, 2026, which became effective immediately. Under this plan, Healthcare Triangle may repurchase up to \$2 million of its common shares. The repurchases may occur through open market transactions, privately negotiated deals, or other methods compliant with U.S. securities laws and regulations.
  • Execution Methods: The company may conduct repurchases in accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and may use Rule 10b5-1 trading plans, enabling systematic and compliant buybacks.
  • Management Discretion: The timing, volume, and nature of repurchases will be determined by management based on market conditions, the trading price of HCTI stock, corporate liquidity needs, legal requirements, and other relevant factors, providing flexibility for opportunistic action.
  • No Obligation to Repurchase Full Amount: The program does not obligate the company to repurchase any particular amount of shares and may be suspended, modified, or discontinued at any time at the company’s discretion. Shares purchased can be held as treasury stock or retired.
  • Funding: The repurchases may be funded using available cash, cash equivalents, or other liquidity sources.
  • Implementation: The company’s officers are authorized to engage qualified brokers and make all necessary regulatory filings to execute the plan.

Comments from Management

“The approval of this share repurchase program reflects the Board’s commitment to prudent capital allocation and its confidence in the Company’s long-term strategy,” said David Ayanoglou, Chief Financial Officer. “The program provides the Company with flexibility to opportunistically repurchase shares while continuing to support our operational and strategic priorities.”

Implications for Shareholders and Potential Market Impact

  • Potential Share Price Support: Share repurchase programs are generally viewed positively by the market, as they can reduce the number of outstanding shares, potentially increasing earnings per share and supporting the stock price.
  • Signal of Board’s Confidence: This action signals Board and management confidence in HCTI’s long-term prospects and strategy, which may be price-sensitive information for the market.
  • Capital Allocation Discipline: The plan demonstrates prudent capital management, balancing shareholder returns with ongoing investment in the business.
  • Flexibility and Uncertainty: Investors should note that the program is discretionary—there is no guarantee that the full \$2 million will be utilized, and the timing and scale of purchases will depend on market and company conditions.

About Healthcare Triangle, Inc.

Healthcare Triangle, based in Pleasanton, California, is a technology-driven company focused on supporting healthcare organizations—including hospitals, payers, and life science companies—in leveraging data and technology for improved health outcomes. The company is recognized for its expertise in digital transformation, including cloud enablement, managed services, security and compliance, data lifecycle management, interoperability, and clinical/business performance optimization. Healthcare Triangle’s proprietary platforms, such as CloudEz™ and DataEz™, have achieved HITRUST r2 certification, underscoring the firm’s commitment to high standards of data protection and information security.

Forward-Looking Statements and Risks

The company cautions investors that statements regarding the timing, amount, and method of share repurchases, as well as other forward-looking statements about revenue growth, margin expansion, and market opportunities, are subject to risks and uncertainties. Actual results may differ materially due to changes in market conditions, client demand, regulatory developments, and execution risks. Shareholders are advised not to place undue reliance on forward-looking statements.

Investor Contact


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with professional advisors before making any investment decisions. Forward-looking statements are subject to risks and uncertainties, and actual outcomes may differ materially from those expressed herein.




View Healthcare Triangle, Inc. Historical chart here



Lunai Bioworks Inc. Receives Nasdaq Delisting Notice – 8-K Filing Details, Company History, and Key Information

LUNAI BIOWORKS, INC. - Nasdaq Delisting Notice and Investor ...

Invesco DB Agriculture Fund (DBA) Annual Report 2025 – Index Weights, Risks, and Financial Analysis

Invesco DB Agriculture Fund 2025 Annual Report: Key Points &...

Turning Point Brands, Inc. 2025 Annual Report: Business Overview, Financials, Segments & Risk Factors (TPB 10-K)

Turning Point Brands, Inc. 2025 Annual Report — Key Investor...

   Ad